The researchers got to a solution so fast in part because much of the basic research and preclinical testing on animal models had been done in 2003 in response to the SARS pandemic.21 The SARS crisis had ebbed before the vaccine development was completed. This time round, the global vaccine race developed a gigantic momentum.
